Scientific activity at VHIO is structured across four major programs: Preclinical Research, Translational Research, Clinical Research and Core Technologies.

As part of VHIO´s structural reorganization, translational research has now broken out as a main VHIO Program led by Joan Seoane. Currently incorporating the Stem Cells and Cancer Group headed by Héctor G. Palmer and Joan Soeane´s Gene Expression and Cancer Group, the Translational Research Program is expected to expand with additional groups of excellence. This will be facilitated through the forthcoming construction of the new CELLEX Building.

VHIO: Working together to advance personalized and targeted therapies against cancer

VHIO´s preclinical research activities have been regrouped as another major VHIO program. The Preclinical Research Program led by Joaquí­n Arribas now incorporates his Growth Factors Group along with that of José Baselga – Experimental Therapeutics, Josep Villanueva – Tumor Biomarkers, and the Mouse Models of Cancer Therapies Group headed by Laura Soucek. Thanks to the forthcoming construction of the CELLEX building this Program will also expand its research lines by incorporating new groups in the future.

VHIO: Working together to advance personalized and targeted therapies against cancer

VHIO´s Clinical Research Program directed by Josep Tabernero, will continue to incorporate the following groups:

Breast Cancer and Melanoma led by Javier Cortes, Head, Neck and Gynecological Tumors headed by Josep Maria del Campo, Josep Tabernero´s Gastrointestinal Tumor Group, Genitourinary, CNS Tumors, Sarcoma and Cancer of Unknown Primary Site Program Group directed by Joan Carles, Enriqueta Felip’s Thoracic Tumor Group, Radiation Oncology under Jordi Giralt´s leadership, High Risk and Cancer Prevention Group led by Judith Balmaña, Hematology Oncology headed by Francesc Bosch, and Oncogenetics Group led by Orland Dí­ez.

VHIO´S clinical research activity continues to be supported by essential core services including the Clinical Trials Office whose activities are headed by Irene Marimon, Gemma Sala and Susana Muñoz, the Clinical Research Nurse Unit supervised by Nines Peñuelas, and the Oncology Pharmaceutical Care Program Unit led by Maria-Josep Carreras Soler and Laura Soler Maños Pujol, as well as database and statistical management.

To deliver on the necessary expansion ahead, this Program will also extend its research through the future incorporation of new groups.

VHIO: Working together to advance personalized and targeted therapies against cancer

VHIO´s Cancer Genomics, Proteomics and Molecular Pathology Groups led by Ana Vivancos, Francesc Canals and Santiago Ramón y Cajal respectively will continue to function as key research groups in their own right whereby the appointed PIs will pursue, implement and develop independent research projects.

Reporting directly to VHIO´s Scientific Director, they will also be responsible for maintaining and developing VHIO´s core technologies. All these activities will now be grouped within the Core Technologies Program with Josep Tabernero, Joan Seoane, and Joaquin Arribas acting in a scientific advisory capacity in Molecular Pathology, Genomics, and Proteomics accordingly.

VHIO: Working together to advance personalized and targeted therapies against cancer


Click here to view VHIO’s organizational chart

Executive Board

It includes the Director, the Preclinical Research Director, the Translational Research Director, the Clinical Research Director; and the Managing Director.

In general terms the Executive Board is responsible for all structural or scientific matters of general interest and executing the recommendations of other bodies.

Main functions:

  • Coordination and strategic planning of research and knowledge transfer of the institute
  • Driving the research programs
  • Monitoring and coordination of the execution of scientific activity, the center’s strategic plan and the annual plan of activities
  • Promotion and development of the scientific community and its constituent members
  • Discussion and preparation of the proposals to be approved by other governing bodies

Research Support Services

The Research Support Services are organized into professionally specialized functional areas.

Research Commission

The Research Commission is made up of the Director and Clinical Research Director, the Preclinical Research Director and the Translational Research Director. The Managing Director and the R&D Office Manager are present as non-voting advisors.